An Analysis of Mindfulness-Based Cognitive Therapy as an Effective Adjuvant in Depression Treatment
Jinhan Zhou
Communications in Humanities Research May 30, 2025 DOI: 10.54254/2753-7064/2024.23434 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review Randomized Peer reviewed |
|---|---|
| Intervention | Mindfulness-based cognitive therapy (MBCT) |
| Topics | Depression Meditation |
| Key findings | The authors report that randomized controlled trials show MBCT is effective as an adjuvant treatment for depression and in preventing relapse, and suggest that patients who are more receptive and open-minded toward the therapy are more likely to benefit, even when initial acceptance is low but attitude changes during treatment. They propose that guiding patients in this way could improve outcomes and that future research might allow MBCT to replace drug treatment. |
Abstract
A large number of studies have demonstrated the effectiveness of mindfulness- based cognitive therapy (MBCT) in the adjuvant treatment of depression, and the significant effect of MBCT in inhibiting the recurrence of depression, most of these studies are randomized controlled trials. These studies compared a group of MBCT combined with conventional treatment and conventional treatment to ensure the accuracy of the experimental results. We can see that in the adjuvant treatment of patients with MBCT, those who are more receptive and open-minded to this therapy are more likely to benefit from it. Even if the patient does not accept it initially, changes in the patient's attitude during treatment can allow the treatment to work. If we can guide patients in this way, The treatment of MBCT may achieve a better effect, and further research in the future may enable RCT to play a role alone in the treatment of patients with depression, enabling RCT to replace drug treatment.
Comparable studies
Other narrative reviews on depression, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Synaptic Dysfunction in Depression: Potential Therapeutic Targets | 2012 | Review | |
| Mindfulness-Based Cognitive Therapy for Depression: A New Approach to Preventing Relapse | 2003 | Review | |
| Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation Adults with treatment-resistant depression | 2021 | Review | |
| Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function. General population | 2019 | Integrative review | |
| Sudarshan Kriya Yogic Breathing in the Treatment of Stress, Anxiety, and Depression: Part II—Clinical Applications and Guidelines | 2005 | Review |
Citations in the library
Cites 6
- A qualitative study of mindfulness‐based cognitive therapy for depression British Journal of Medical Psychology June 1, 2001
- Follow-up outcomes of Mindfulness-Based Cognitive Therapy (MBCT) for patients with chronic, treatment-resistant depression. Journal of Affective Disorders May 1, 2023
- Effects of Mindfulness-Based Cognitive Therapy on Major Depressive Disorder with Multiple Episodes: A Systematic Review and Meta-Analysis. International Journal of Environmental Research and Public Health January 14, 2023
- Mindfulness‐based cognitive therapy for patients with chronic, treatment‐resistant depression: A pragmatic randomized controlled trial Depression and Anxiety August 8, 2018
- A randomized controlled trial of Mindfulness-Based Cognitive Therapy (MBCT) versus treatment-as-usual (TAU) for chronic, treatment-resistant depression: study protocol BMC Psychiatry November 9, 2015
and 1 more in the library